Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support (vol 87, pg 83, 2007)

被引：0
|
作者：
Simunic, V.
Tomic, V.
Tomic, J.
Nizic, D.
机构：
来源：
FERTILITY AND STERILITY | 2007年 / 88卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：254 / 254
页数：1
相关论文
共 12 条
  • [1] Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support
    Simunic, Velimir
    Tomic, Vlatka
    Tomic, Jozo
    Nizic, Dinko
    FERTILITY AND STERILITY, 2007, 87 (01) : 83 - 87
  • [2] COMPARISON OF THE EFFICACY OF TWO VAGINAL PROGESTERONE FORMULATIONS, CRINONE 8% GEL AND UTROGESTAN CAPSULES, USED FOR LUTEAL SUPPORT IN BLASTOCYST STAGE EMBRYO TRANSFERS
    Wang, Li-Jung
    Huang, Fu-Jen
    Kung, Fu-Tsai
    Lin, Pin -Yao
    Chang, Shiuh Young
    Lan, Kuo-Chung
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2009, 48 (04): : 375 - 379
  • [3] Efficacy and tolerability of vaginal progesterone capsules (Utrogest™ 200) compared with progesterone gel (Crinone™ 8%) for luteal phase support during assisted reproduction
    Kleinstein, J
    FERTILITY AND STERILITY, 2005, 83 (06) : 1641 - 1649
  • [4] Vaginal use of micronized progesterone for luteal support. A randomized study comparing Utrogestan® and Crinone® 8%
    Michnova, Lucie
    Dostal, Jiri
    Kudela, Milan
    Hamal, Petr
    Langova, Katerina
    BIOMEDICAL PAPERS-OLOMOUC, 2017, 161 (01): : 86 - 91
  • [5] Luteal support after in-vitro fertilization: Crinone 8%, a sustained release vaginal progesterone gel, versus Utrogestan, an oral micronized progesterone
    Pouly, JL
    Bassil, S
    Frydman, R
    Hedon, B
    Nicollet, B
    Prada, Y
    Antoine, JM
    Zambrano, R
    Donnez, J
    HUMAN REPRODUCTION, 1996, 11 (10) : 2085 - 2089
  • [6] Comparison of the efficacy and safety of two formulations of micronized progesterone (Ellios™ and Utrogestan™) used as luteal phase support after in vitro fertilization
    Germond, M
    Capelli, P
    Bruno, G
    Vesnaver, S
    Senn, A
    Rouge, N
    Biollaz, J
    FERTILITY AND STERILITY, 2002, 77 (02) : 313 - 317
  • [7] Coniparison of the efficacy and tolerability of two formulations of vaginal progesterone for luteal pilase support in frozen embryo transfer cycles
    Lan, V. T. N.
    Tuan, P.
    Canh, L.
    Tuong, H.
    Howles, C. M.
    FERTILITY AND STERILITY, 2007, 88 : S164 - S164
  • [8] Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support following blastocyst cryopreserved single embryo transfer: a retrospective cohort study
    Jennifer B. Bakkensen
    Catherine Racowsky
    Ann M. Thomas
    Andrea Lanes
    Mark D. Hornstein
    Fertility Research and Practice, 6 (1)
  • [9] The safety and efficacy of vaginal micronized progesterone (Crinone® 8%) indicated as luteal phase support evaluated in a large prospective, multicenter, multinational study in ART.
    Kaplan, B
    FERTILITY AND STERILITY, 2002, 78 (03) : S235 - S235
  • [10] Vaginal progesterone gel is non-inferior to intramuscular progesterone in efficacy with acceptable tolerability for luteal phase support: A prospective, randomized, multicenter study in China
    Chi, Hongbin
    Li, Rong
    Qiao, Jie
    Chen, Xiujuan
    Wang, Xingling
    Hao, Guimin
    Wu, Qiongfang
    Cao, Yunxia
    Cai, Liyi
    Ye, Hong
    Zhu, Yimin
    Wang, Shuyu
    Zhang, Xuehong
    Zhang, Cuilian
    Zhang, Yunshan
    Lv, Qun
    Sun, Yingpu
    Li, Hong
    Huang, Xuefeng
    Wang, Fang
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2019, 237 : 100 - 105
12